XEOMIN®

Xeomin’s unique formulation without unnecessary proteins had an excellent performance profile. Study data showed high patient satisfaction and continued efficacy over multiple treatment cycles.

“Medical aesthetics is all about helping people look and feel their best so they can live better lives overall,” said lead investigator, Dr. John H. Joseph, MD. “In clinical practice, we are seeing an increasing demand for treating all three delicate areas of the face and these new data offer promising results with incobotulinumtoxinA as a potential single treatment that might help us to better serve our patients’ needs.”